Table 1 Baseline characteristics of the patients
Characteristic | Value (n = 47) |
|---|---|
aPatient age (years) | 50 (20–69) |
Patient sex | |
Males | 24 (51.1) |
Females | 23(48.9) |
Disease type | |
Multiple myloma | 23 (48.9) |
Lymphoma: | 24 (51.1) |
Anaplastic T cell lymphoma | 2 (4.3) |
Breast lymphoma | 1 (2.1) |
DLBCL | 10 (21.3) |
Hodgkin lymphoma | 9 (19.1) |
Mantle lymphoma | 2 (4.3) |
Performance status | |
0 | 40 (85.1) |
1 | 7 (14.9) |
Disease status at transplant | |
CR | 43 (91.5) |
Refractory | 4 (8.5) |
Conditioning | |
BEAM | 22 (46.8) |
LEAM | 2 (4.3) |
High-dose melphalan | 23 (48.9) |
Melphalan dosage | |
200 mg/m2 | 23 (48.9) |
140 mg/m2 | 24 (51.1) |
Dose of CD34 cells (106/kg) | 4.15 (2.3–10) |
Pre-transplant comorbidities | |
No | 37 (78.7) |
Yes | 10 (21.3) |
Weight at admission (kg) | 80 (54–122) |
aDiagnosis to transplant lag period (month) | 13 (8–36) |